Picture of Torrent Pharmaceuticals logo

TORNTPHARM Torrent Pharmaceuticals Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Torrent Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2019
March 31st
R2020
March 31st
C2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line5,61711,86615,26312,25918,472
Depreciation
Non-Cash Items8,0052,2183,3516,8782,307
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1,818-6,699-5,138-7,729-3,574
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities17,98113,92920,05418,03024,270
Capital Expenditures-6,628-4,068-3,352-2,026-5,739
Purchase of Fixed Assets
Other Investing Cash Flow Items4,2166,054-1,14359.4-18,414
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-2,4131,986-4,494-1,966-24,153
Financing Cash Flow Items-5,034-4,854-3,561-2,577-3,030
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-13,145-15,490-16,508-17,811774
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2,380731-893-1,7421,101